The study included 44 patients in the sunitinib group and 41 patients in the placebo group; all received a chemotherapy regimen of cisplatin or carboplatin and
etoposide after enrollment but prior to randomization.
Not exact matches
Seventeen patients received GO alone when MRD was detected
after two rounds of chemotherapy with the drugs cytarabine, daunorubicin and
etoposide.